These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15017493)
1. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Chial HJ; Camilleri M; Ferber I; Delgado-Aros S; Burton D; McKinzie S; Zinsmeister AR Clin Gastroenterol Hepatol; 2003 May; 1(3):211-8. PubMed ID: 15017493 [TBL] [Abstract][Full Text] [Related]
2. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Chial HJ; Camilleri M; Burton D; Thomforde G; Olden KW; Stephens D Am J Physiol Gastrointest Liver Physiol; 2003 Jan; 284(1):G130-7. PubMed ID: 12488239 [TBL] [Abstract][Full Text] [Related]
3. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Sweetser S; Busciglio IA; Camilleri M; Bharucha AE; Szarka LA; Papathanasopoulos A; Burton DD; Eckert DJ; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G295-301. PubMed ID: 19033530 [TBL] [Abstract][Full Text] [Related]
4. Effect of the α2δ ligand, pregabalin, on colonic sensory and motor functions in healthy adults. Iturrino J; Camilleri M; Busciglio I; Burton D; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G377-84. PubMed ID: 21596994 [TBL] [Abstract][Full Text] [Related]
5. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Esfandyari T; Camilleri M; Busciglio I; Burton D; Baxter K; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G137-45. PubMed ID: 17395895 [TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. Davidson JR; DuPont RL; Hedges D; Haskins JT J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635 [TBL] [Abstract][Full Text] [Related]
7. Differential physiological effects of a low dose and high doses of venlafaxine in major depression. Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006 [TBL] [Abstract][Full Text] [Related]
8. Venlafaxine extended-release: a review of its use in the management of major depression. Wellington K; Perry CM CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036 [TBL] [Abstract][Full Text] [Related]
9. Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. Meoni P; Salinas E; Brault Y; Hackett D J Clin Psychiatry; 2001 Nov; 62(11):888-93. PubMed ID: 11775049 [TBL] [Abstract][Full Text] [Related]
10. [Psychopharmacological profile of venlafaxine]. Bourin M Encephale; 1999 Jun; 25 Spec No 2():21-2; discussion 23-5. PubMed ID: 10434156 [TBL] [Abstract][Full Text] [Related]
11. Evidence of the dual mechanisms of action of venlafaxine. Harvey AT; Rudolph RL; Preskorn SH Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491 [TBL] [Abstract][Full Text] [Related]
12. Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome. Iturrino J; Camilleri M; Busciglio I; Burton D; Zinsmeister AR Dig Liver Dis; 2014 Feb; 46(2):113-8. PubMed ID: 24095618 [TBL] [Abstract][Full Text] [Related]
13. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat. Béïque J; de Montigny C; Blier P; Debonnel G Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562 [TBL] [Abstract][Full Text] [Related]
14. Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans. Odunsi ST; Camilleri M; Bharucha AE; Papathanasopoulos A; Busciglio I; Burton D; Zinsmeister AR Dig Dis Sci; 2010 Mar; 55(3):709-15. PubMed ID: 19291400 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein. Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM Br J Clin Pharmacol; 1999 Sep; 48(3):345-54. PubMed ID: 10510145 [TBL] [Abstract][Full Text] [Related]
16. Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. O'Hanlon JF; Robbe HW; Vermeeren A; van Leeuwen C; Danjou PE J Clin Psychopharmacol; 1998 Jun; 18(3):212-21. PubMed ID: 9617980 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Stahl SM; Entsuah R; Rudolph RL Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062 [TBL] [Abstract][Full Text] [Related]
18. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005 [TBL] [Abstract][Full Text] [Related]
19. Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone. Kuloglu M; Ekinci O; Caykoylu A J Psychopharmacol; 2010 Apr; 24(4):627-8. PubMed ID: 19264817 [No Abstract] [Full Text] [Related]
20. Buspirone to improve compliance in venlafaxine-induced movement disorder. Pavlovic ZM Int J Neuropsychopharmacol; 2004 Dec; 7(4):523-4. PubMed ID: 15383159 [No Abstract] [Full Text] [Related] [Next] [New Search]